Frequency and risk of noncardiac surgery after drug-eluting stent implantation

Catheterization and Cardiovascular Interventions

Volumn 77, Issue 7, 2011, Pages 972-976

  Gandhi, Nainesh K ^a   Abdel Karim, Abdul Rahman R ^a   Banerjee, Subhash ^a   Brilakis, Emmanouil S ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

clopidogrel; drug eluting stent; noncardiac surgery; perioperative risk

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; RAPAMYCIN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BLEEDING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MINOR SURGERY; NONCARDIAC SURGERY; PERIOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; STENT THROMBOSIS; SURGICAL MORTALITY; SURGICAL RISK; SYNCOPE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CHI-SQUARE DISTRIBUTION; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE; TEXAS; THROMBOSIS; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79958285705     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22744     Document Type: Article

References (19)

1. Brilakis E, Banerjee S, Berger P,. Perioperative management of coronary stents. J Am Coll Cardiol 2007; 49: 2145-2150.
2. Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE,. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000; 35: 1288-1294. (Pubitemid 30206904)
3. Wilson SH, Fasseas P, Orford JL, Lennon RJ, Horlocker T, Charnoff NE, Melby S, Berger PB,. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003; 42: 234-240. (Pubitemid 36851411)
4. Layland J, Jellis C, Whitbourn R,. Extremely late drug-eluting stent thrombosis: 2037 days after deployment. Cardiovasc Revasc Med 2009; 10: 55-57.
5. Varghese I, Ummer A, Roesle M, Banerjee S, Brilakis ES,. Recurrent late drug-eluting stent thrombosis upon discontinuation of antiplatelet therapy. Cardiovasc Revasc Med. 2008; 9: 179-181. (Pubitemid 351905938)
6. Compton PA, Zankar AA, Adesanya AO, Banerjee S, Brilakis ES,. Risk of noncardiac surgery after coronary drug-eluting stent implantation. Am J Cardiol 2006; 98: 1212-1213. (Pubitemid 44584105)
7. Schouten O, van Domburg RT, Bax JJ, de Jaegere PJ, Dunkelgrun M, Feringa HHH, Hoeks SE, Poldermans D,. Noncardiac surgery after coronary stenting: Early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 2007; 49: 122-124. (Pubitemid 46026891)
8. Brotman DJ, Bakhru M, Saber W, Aneja A, Bhatt DL, Tillan-Martinez K, Jaffer AK,. Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: A retrospective cohort study. J Hosp Med 2007; 2: 378-384.
9. Kim HL, Park KW, Kwak JJ, Kim YS, Sir JJ, Lee SJ, Lee HY, Chang HJ, Kang HJ, Cho YS, et al. Stent-related cardiac events after non-cardiac surgery: drug-eluting stent vs. bare metal stent. Int J Cardiol 2008; 123: 353-354.
10. Godet G, Le Manach Y, Lesache F, Perbet S, Coriat P,. Drug-eluting stent thrombosis in patients undergoing non-cardiac surgery: is it always a problem? Br J Anaesth 2008; 100: 472-477. (Pubitemid 351773621)
11. Rhee SJ, Yun KH, Lee SR, Chae JK, Nam CW, Jun DH, Jeong JW,. Drug-eluting stent thrombosis during perioperative period. Int Heart J 2008; 49: 135-142. (Pubitemid 351907733)
12. Rabbitts JA, Nuttall GA, Brown MJ, Hanson AC, Oliver WC, Holmes DR, Rihal CS,. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008; 109: 596-604.
13. Cruden NL, Harding SA, Flapan AD, Graham C, Wild SH, Slack R, Pell JP, Newby DE,. Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circ Cardiovasc Interv 2010; 3: 236-242.
14. van Kuijk JP, Flu WJ, Schouten O, Hoeks SE, Schenkeveld L, de Jaegere PP, Bax JJ, van Domburg RT, Serruys PW, Poldermans D,. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents. Am J Cardiol 2009; 104: 1229-1234.
15. Assali A, Vaknin-Assa H, Lev E, Bental T, Ben-Dor I, Teplitsky I, Brosh D, Fuchs S, Eidelman L, Battler A, et al. The risk of cardiac complications following noncardiac surgery in patients with drug eluting stents implanted at least six months before surgery. Catheter Cardiovasc Interv 2009; 74: 837-843.
16. Anwaruddin S, Askari AT, Saudye H, Batizy L, Houghtaling PL, Alamoudi M, Militello M, Muhammad K, Kapadia S, Ellis SG,. Characterization of post-operative risk associated with prior drug-eluting stent use. JACC Cardiovasc Interv 2009; 2: 542-549.
17. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 2007; 50: e159-e241. (Pubitemid 47566436)
18. Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB, Moliterno DJ, O'Gara P, Whitlow P,. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association. American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 2007; 49: 734-739. (Pubitemid 46210116)
19. Tompkins C, Cheng A, Dalal D, Brinker JA, Leng CT, Marine JE, Nazarian S, Spragg DD, Sinha S, Halperin H, et al. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation. J Am Coll Cardiol 2010; 55: 2376-2382.